SG11202107925YA - Pyrrolopyrimidine derivative and use thereof - Google Patents
Pyrrolopyrimidine derivative and use thereofInfo
- Publication number
- SG11202107925YA SG11202107925YA SG11202107925YA SG11202107925YA SG11202107925YA SG 11202107925Y A SG11202107925Y A SG 11202107925YA SG 11202107925Y A SG11202107925Y A SG 11202107925YA SG 11202107925Y A SG11202107925Y A SG 11202107925YA SG 11202107925Y A SG11202107925Y A SG 11202107925YA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrrolopyrimidine derivative
- pyrrolopyrimidine
- derivative
- Prior art date
Links
- 150000004944 pyrrolopyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910106140 | 2019-02-01 | ||
| CN201910572538 | 2019-06-26 | ||
| PCT/CN2020/073859 WO2020156459A1 (zh) | 2019-02-01 | 2020-01-22 | 吡咯并嘧啶衍生物及其用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202107925YA true SG11202107925YA (en) | 2021-08-30 |
Family
ID=71841643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107925YA SG11202107925YA (en) | 2019-02-01 | 2020-01-22 | Pyrrolopyrimidine derivative and use thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220064172A1 (de) |
| EP (1) | EP3919498B3 (de) |
| JP (1) | JP7228702B2 (de) |
| KR (1) | KR102629358B1 (de) |
| CN (1) | CN111518101B (de) |
| AU (1) | AU2020213569B2 (de) |
| BR (1) | BR112021014777A2 (de) |
| CA (1) | CA3126176C (de) |
| DK (1) | DK3919498T6 (de) |
| IL (1) | IL284994B2 (de) |
| SG (1) | SG11202107925YA (de) |
| WO (1) | WO2020156459A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022004099A2 (pt) * | 2019-09-06 | 2022-05-31 | Wuhan Humanwell Innovative Drug Res And Development Center Limited Company | Composto, composição farmacêutica, uso do composto, e, método para o tratamento de uma doença relacionada ao atx |
| JP2023535846A (ja) * | 2020-07-28 | 2023-08-21 | 武漢人福創新薬物研発中心有限公司 | 含窒素複素環化合物の塩及びその塩の固体形態、医薬組成物並びに用途 |
| CN113999235A (zh) * | 2020-07-28 | 2022-02-01 | 武汉人福创新药物研发中心有限公司 | 含氮杂环化合物的固体形式及其药物组合物和用途 |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140008987A (ko) | 2012-07-13 | 2014-01-22 | 삼성전자주식회사 | 필기 이미지 인식을 이용한 어플리케이션 제어 방법 및 장치 |
| TWI499591B (zh) * | 2013-01-11 | 2015-09-11 | Lilly Co Eli | 雙環嘧啶化合物 |
| TW201520219A (zh) * | 2013-03-12 | 2015-06-01 | Lilly Co Eli | 咪唑並吡啶化合物 |
| JP6435323B2 (ja) | 2013-06-19 | 2018-12-05 | ガラパゴス・ナムローゼ・フェンノートシャップＧａｌａｐａｇｏｓ Ｎ．Ｖ． | 炎症性障害の治療のための新規化合物及びその医薬組成物 |
-
2020
- 2020-01-22 DK DK20748342.1T patent/DK3919498T6/da active
- 2020-01-22 JP JP2021541309A patent/JP7228702B2/ja active Active
- 2020-01-22 AU AU2020213569A patent/AU2020213569B2/en active Active
- 2020-01-22 CN CN202010074393.6A patent/CN111518101B/zh active Active
- 2020-01-22 US US17/423,482 patent/US20220064172A1/en active Pending
- 2020-01-22 WO PCT/CN2020/073859 patent/WO2020156459A1/zh active Application Filing
- 2020-01-22 IL IL284994A patent/IL284994B2/en unknown
- 2020-01-22 SG SG11202107925YA patent/SG11202107925YA/en unknown
- 2020-01-22 KR KR1020217023127A patent/KR102629358B1/ko active IP Right Grant
- 2020-01-22 BR BR112021014777-2A patent/BR112021014777A2/pt unknown
- 2020-01-22 CA CA3126176A patent/CA3126176C/en active Active
- 2020-01-22 EP EP20748342.1A patent/EP3919498B3/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210108985A (ko) | 2021-09-03 |
| JP2022518224A (ja) | 2022-03-14 |
| CN111518101A (zh) | 2020-08-11 |
| EP3919498B3 (de) | 2024-09-04 |
| JP7228702B2 (ja) | 2023-02-24 |
| AU2020213569B2 (en) | 2022-10-13 |
| EP3919498A1 (de) | 2021-12-08 |
| US20220064172A1 (en) | 2022-03-03 |
| BR112021014777A2 (pt) | 2021-09-28 |
| EP3919498B1 (de) | 2024-07-03 |
| IL284994A (en) | 2021-09-30 |
| IL284994B2 (en) | 2024-10-01 |
| CA3126176C (en) | 2023-08-29 |
| CA3126176A1 (en) | 2020-08-06 |
| AU2020213569A1 (en) | 2021-08-05 |
| DK3919498T6 (da) | 2024-10-07 |
| KR102629358B1 (ko) | 2024-01-24 |
| NZ778087A (en) | 2024-02-23 |
| IL284994B1 (en) | 2024-06-01 |
| CN111518101B (zh) | 2022-07-29 |
| WO2020156459A1 (zh) | 2020-08-06 |
| EP3919498A4 (de) | 2022-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285178A (en) | compounds and their use | |
| IL285177A (en) | compounds and their use | |
| IL284994A (en) | Pyrrolopyrimidine derivative and its use | |
| EP3760632A4 (de) | Pyrazolopyrimidinderivat und verwendung davon | |
| EP3981769A4 (de) | Pyrrolopyrimidinverbindung und ihre verwendung | |
| GB201711234D0 (en) | Pyrrolopyrimidine and pyrrolopyridine derivatives | |
| IL286497A (en) | compounds and their use | |
| IL284514A (en) | Halo-allylamine compounds and their use | |
| IL291499A (en) | Azaquinoline compounds and their uses | |
| EP4011898A4 (de) | 2-hydroxy-5-pregnan-20-on-derivate und verwendung davon | |
| IL277749A (en) | Palladianolide compounds and their use | |
| IL286079A (en) | History of imidazolonylquiniline and their medical uses | |
| IL282527A (en) | 5-Azaindazole history and their use | |
| IL285118A (en) | compounds and their uses | |
| IL284764A (en) | compounds and their uses | |
| IL280644A (en) | Magnesium serine compound and its use | |
| GB201918541D0 (en) | Therapeutic compounds and their use | |
| IL282526A (en) | 5-Azaindazole history and their use | |
| EP4051270A4 (de) | 4-amino-imodazochinolinverbindungen und verwendungen davon | |
| EP3853213A4 (de) | Abschirmungsmittel und deren verwendung | |
| IL289531A (en) | cd38 binding agents and uses thereof | |
| IL287503A (en) | Thio-semicarbazide compounds and their use | |
| IL288828A (en) | Binding factors - cd38 and their use | |
| GB201906914D0 (en) | Substituted naphtahlene diimdes and their use | |
| GB201905520D0 (en) | Compounds and their therapeutic use |